Vectron Biosolutions AS is a biotechnology startup with the slogan "Unique solutions to unique problems." Established in 2008, Vectron specializes in developing robust and cost-efficient microbial protein production processes. Their proprietary portfolio of expression technologies enables the development of bacterial strains that produce specific proteins at optimum titers and quality.
The most recent milestone for Vectron Biosolutions is a $2.70M Series A investment led by Dynamk Capital on 17 June 2021. This injection of capital underscores investor confidence in the company's innovative approach and ability to address critical challenges within the health care and life sciences sectors.
